ArticleFrontiers in genetics2025
FusDRM-m5C: a hybrid model for accurate prediction of 5-methylcytosine modification sites based on feature fusion and attention mechanism.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The precise identification of 5-methylcytosine (m5C), an epitranscriptomic modification fundamental to RNA function, is crucial yet proves difficult to achieve experimentally. Consequently, computational prediction offers a promising avenue; however, refining its predictive accuracy and ensuring its robustness remain ongoing objectives. To address these limitations, this study introduces a deep learning framework designed for highly accurate m5C site prediction from RNA sequences. Methods: We propose FusDRM-m5C, a deep learning framework featuring a multi-branch architecture designed to process three distinct feature types: one-hot vector representation (one-hot), Z-curve-based geometrical features (Z-curve), and local RNA secondary structure (RSS). Each feature type is processed by a separate, parallel branch. Within each branch, a Dilated Convolutional Neural Network (DCNN) captures multi-scale patterns, followed by a Multi-Head Self-Attention (MHSA) mechanism with residual connections to weigh context-dependent information. For feature fusion, the high-level representations from the three branches are then integrated via concatenation. This fused feature vector is subsequently fed into a final fully connected network, which generates the prediction probability for precise m5C site identification. Results: The performance of FusDRM-m5C was rigorously evaluated using both 5-fold cross-validation (CV) and independent dataset testing. On the 5-fold CV benchmark dataset, the model achieved high predictive accuracy, reflected by a Sensitivity (Sn) reaching 0.995, Specificity (Sp) of 0.971, Accuracy (ACC) at 0.983, Matthews correlation coefficient (MCC) measuring 0.966, and an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.997. Crucially, when assessed on an independent test dataset, the model maintained strong generalization capability, attaining an Sn of 0.900, Sp of 0.965, Acc of 0.933, MCC of 0.867, and an AUC of 0.986. Furthermore, we assessed the cross-species prediction performance of FusDRM-m5C. The results demonstrated that the model consistently maintained high accuracy and robustness across datasets from multiple species, outperforming several existing state-of-the-art methods. Discussion: The proposed FusDRM-m5C model demonstrates highly accurate and robust prediction of m5C sites, comparing favorably with existing methods. Its architecture effectively integrates diverse biological features through distinct processing pathways fused via attention, offering a powerful tool for m5C identification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.